Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Paradigm Spine LLC

This article was originally published in Start Up

Executive Summary

Paradigm Spine is building a pipeline of dynamic stabilization devices based on two core technology platforms: coflex interspinous spacers for stenosis and Orthobiom implants for adolescent idiopathic scoliosis. The three-year-old company is rolling out products at a rapid pace: it will have five devices on ex-US markets by the middle of this year.

You may also be interested in...



Vertebral Compression Fracture Market Update: New Products Gain Traction

Vertebral compression fracture repair remains one of the fastest growing segments of the spinal market. Although the VCF industry as a whole remains strong, competitive dynamics in this industry are beginning to shift, with a growing number of new products now available to address this expanding market.

Artificial Discs: Where Do We Go from Here?

Artificial discs are experiencing a cooling trend owing to an expected reduction in CMS reimbursement for both cervical and lumbar disc replacement. Many motion preservation companies are reaching critical regulatory milestones that will likely require a step-up in funding to conduct the large scale clinical studies needed to gain PMA approval. Today, companies in this sector are faced with the troubling task of either scaling back R&D programs to conserve cash or raising additional capital to take the next steps. This article first appeared in the June 2008 issue of In Vivo.

Artificial Discs: Experiencing a Cooling Trend

Artificial discs are experiencing a cooling trend owing to an expected reduction in CMS reimbursement for both cervical and lumbar disc replacement. Many motion preservation companies are reaching critical regulatory milestones that will likely require a step-up in funding to conduct the large scale clinical studies needed to gain PMA approval. Today, companies in this sector are faced with the troubling task of either scaling back R&D programs to conserve cash or raising additional capital to take the next steps.

Related Content

Topics

Related Companies

Related Deals

UsernamePublicRestriction

Register

MT037488

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel